Clinical Trials List
Protocol NumberABU001
Active
2024-06-01 - 2027-12-31
Phase I
Recruiting3
-
Trial Applicant
Efficient Pharma Management Corp.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Huan-Tze Lin Division of Thoracic Medicine
- Jia-Ruey Tsai Division of Thoracic Medicine
- 高冠鈞 Division of Hematology & Oncology
- Shang-Fu Hsu Division of Thoracic Medicine
- Kai-Ling Lee Division of Thoracic Medicine
- Sheng-Yu Chen Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Hung Chen Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Yu-Fang Huang Division of Obstetrics & Gynecology
- Chun-Hui Lee Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- Peng-Chan Lin Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- 蘇勇曄 Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- 黃盈慈 Division of Hematology & Oncology
- 顏志傑 Division of Hematology & Oncology
- 吳珮瑩 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chen-Yuan Lin Division of Hematology & Oncology
- 王秀慈 Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
67 participants
-
Global
67 participants
